Summary : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the companies have submitted an application to the U.S. Food…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
-
-
CompaniesModernaPatent LitigationPatentsPfizer
Alnylam Files Patent Infringement Lawsuits Against Pfizer, Moderna
Summary : Alnylam Pharmaceuticals Inc on Thursday filed lawsuits in Delaware federal court against Pfizer Inc and Moderna Inc, claiming their multibillion-dollar…
-
Summary : The initiative will catalyse discovery and early development of antiviral medicines for future pandemics The Novo Nordisk Foundation, Open Philanthropy…
-
Summary : Endo Pharmaceuticals and Endo Health Solutions, makers of Percocet, Opana, and Percodan, have settled with the State of Florida for…
-
Summary : –Japanese pharma Eisai has backed away from its 50:50 profit-sharing arrangement with Biogen for troubled Alzheimer’s therapy Aduhelm, handing over…
-
Summary : Today, the U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol…
-
Summary : The p53 protein protects our cells from cancer and is an interesting target for cancer treatments. The problem is, however,…
-
Summary Merck & Co has announced a deal with King’s College London (KCL) and Wellcome to investigate a new class of painkillers…
-
AstraZenecaCompaniesMerck & CoRegulatoryU.S FDA
AZ, Merck get FDA okay for Lynparza as adjuvant breast cancer therapy
Summary : The FDA has cleared AstraZeneca and Merck & Co’s Lynparza as an adjuvant or neoadjuvant treatment for breast cancer, extending…
-
Summary : AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic…